Dechert LLP’s capital markets team is active on issuer-side engagements in the financial services sector, with notable expertise when it comes to offerings by business development companies (BDCs).
Harry Pangas in Washington DC has deep experience representing BDCs, registered closed-end funds, interval funds, and tender offer funds. Boston-based
Thomas Friedmann has a strong track record advising issuers and investment banks on public and private securities transactions. He also advises alternative asset managers on accessing capital via BDCs and closed-end funds, among other vehicles.
Stephen Leitzell in Philadelphia is noted particularly for his work in the healthcare and tech sectors. The three partners lead the group along with New York-based
Anna Tomczyk, whose varied practice spans Rule 144A and Reg S offerings, among other kinds.
David Rosenthal is active in the life sciences space. Washington DC’s
Matthew Carter is also a key contact in the group.